Analysis of the Global Type 2 Diabetes Therapeutics Market

Analysis of the Global Type 2 Diabetes Therapeutics Market

Market Opportunities for Differentiated Therapeutics

Asia Pacific
Research Code: NC67-01-00-00-00
SKU: LS00114-AP-MR_16955
AvailableYesPDF Download


Special Price $7,500.00 save 25 %

In stock


$7,500.00save 25 %



Type 2 diabetes is one of the most significant global health concerns of modern times. The size of the diabetes therapeutics market has stimulated a vast and growing pipeline of potential new therapies aimed at the unmet needs of tighter glucose control, improved safety profiles, and greater convenience to patients. This research service evaluates the global market for the pharmaceutical management of type 2 diabetes from 2009 to 2017, with 2012 as the base year. Segmentation by drug type (insulin and non-insulin therapeutics) and regional breakdown are provided. Included are products available in the market, products in development, and patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed.

Table of Contents

Executive Summary

  • Executive Summary and Key Findings

Market Overview

  • Overview

Competitive Playbook

  • Market Opportunities

Total Type 2 Diabetes Therapeutics Market

  • Type 2 Diabetes Therapeutics Market

Insulin Segment Breakdown

  • Insulin Segment Analysis

Non–insulin Segment Breakdown

  • Non–insulin Segment Analysis

United States Breakdown

  • United States Analysis

The United Kingdom Breakdown

  • The United Kingdom Analysis

Germany Breakdown

  • Germany Analysis

France Breakdown

  • France Analysis

Italy Breakdown

  • Italy Analysis

Spain Breakdown

  • Spain Analysis

Benelux Breakdown

  • Benelux Analysis

Scandinavia Breakdown

  • Scandinavia Analysis

China Breakdown

  • China Analysis

South Korea Breakdown

  • South Korea Analysis

Malaysia Breakdown

  • Malaysia Analysis

Indonesia Breakdown

  • Indonesia Analysis

Vietnam Breakdown

  • Vietnam Analysis

India Breakdown

  • India Analysis

Customer and End-user Analysis

  • End-user Analysis

Key Companies to Watch

  • Key Companies to Watch

The Last Word

  • The Last Word


  • Additional Information
The packaging industry plays a major role in the pharmaceutical market. It not only provides containment and drug safety, but also ensures identity, convenience of handling, and delivery. It needs to balance complex considerations. Pharmaceutical packaging firms are some of the industrys most innovative companies, as has been evident in the last 10 years. Packaging is a science and has been continuously evolving. In 2014, the pharmaceutical industry has had a variety to choose from (including the prototypes). Europe and other developed markets have become increasingly vigilant in tracking pharmaceutical packaging and stopping drug counterfeit. By 2017, serialisation of drug packages will be mandatory for all manufacturers. Under these circumstances, drug manufacturers have limited or no choice but to comply with the new norms if they want to continue operating in these markets. Pharmaceutical packaging plays an important role in saving costs. By using the latest technologies, drug manufacturers can switch from their existing packaging forms to more innovative designs without spending too much money on R&D. Packaging firms have been always the greatest supporters of the pharmaceutical industry and play a major role in reducing costs. Amcor, CCL Industries, Schott, and MeadWestvaco are some of the major names in the pharmaceutical packaging industry. These firms have been responsible for introducing innovations in pharmaceutical packaging. Some of the ready-for-use prototypes are expected to create a major change in the way drugs will be packaged going forward. The report focuses on important aspects such as, Which are the key companies and regulations to focus on during 2014-2015?, and What are the new technologies that can help the pharmaceutical companies gain an edge over their competitors and reduce cost of packaging? Frost and Sullivan has been tracking the pharmaceutical industry for more than three decades. This research service will essentially help pharmaceutical manufacturers who are looking at innovations as well as cost cutting methods and want to prepare themselves for the European Union regulations that will impact them from 2017.
More Information
No Index No
Podcast No
Author Deborah Toscano
WIP Number NC67-01-00-00-00
Is Prebook No